Meadow Creek Investment Management’s AbbVie ABBV Stock Holding History

Meadow Creek Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$10.7M	Buy	141,624 +52,024	+58%	+$3.57M	0.21%	86
2019 Q2	$6.52M	Sell	89,600 -3,584	-4%	-$282K	0.13%	154
2019 Q1	$7.51M	Sell	93,184 -76,552	-45%	-$6.26M	0.15%	134
2018 Q4	$15.6M	Sell	169,736 -61,712	-27%	-$5.43M	0.36%	65
2018 Q3	$21.9M	Buy	231,448 +45,248	+24%	+$4.29M	0.43%	51
2018 Q2	$17.3M	Buy	186,200 +13,188	+8%	+$1.29M	0.36%	69
2018 Q1	$16.4M	Buy	173,012 +86,632	+100%	+$9.52M	0.36%	63
2017 Q4	$8.35M	Buy	86,380 +65,660	+317%	+$6.19M	0.18%	120
2017 Q3	$1.84M	Sell	20,720 -3,164	-13%	-$241K	0.04%	309
2017 Q2	$1.73M	Sell	23,884 -420	-2%	-$28.2K	0.04%	321
2017 Q1	$1.58M	Sell	24,304 -5,852	-19%	-$368K	0.04%	327
2016 Q4	$1.89M	Buy	+30,156	New	+$1.84M	0.05%	284

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Meadow Creek Investment Management's ABBV Position: Q3 2019 in Review

Meadow Creek Investment Management increased its AbbVie (ABBV) stake by 58% in Q3 2019, buying an estimated $3.57M and bringing the position to 141,624 shares worth $10.7M. The position accounts for 0.21% of the portfolio, ranked #86.

Meadow Creek Investment Management first reported a position in ABBV in Q4 2016 and has held it in 12 quarters since. The position peaked at $21.9M in Q3 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Meadow Creek Investment Management held 141,624 shares of AbbVie worth $10.7M as of Q3 2019.
Meadow Creek Investment Management bought 52,024 AbbVie shares in Q3 2019, an estimated $3.57M.
AbbVie made up 0.21% of Meadow Creek Investment Management's portfolio in Q3 2019, its #86 holding.
Meadow Creek Investment Management first reported a position in AbbVie in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's AbbVie position peaked at $21.9M in Q3 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.